SYLLABUS

GS-3: Achievements of Indians in science & technology; indigenization of technology and developing new technology.

Context: Union Agriculture and Farmers’ Welfare Minister Shivraj Singh Chouhan dedicated India’s first indigenous H5N1 bird flu vaccine to the nation, marking a major milestone in animal healthcare and self-reliance.

About the Indigenous H5N1 Bird Flu Vaccine

  • Developer: ICAR-National Institute of High Security Animal Diseases (NIHSAD), Bhopal, Madhya Pradesh.
  • Target Disease: Highly Pathogenic Avian Influenza (HPAI), commonly known as bird flu.
  • Target Strain: H5N1 virus of Clade 2.3.2.1a.
  • Target Species: Chickens and poultry birds; it is not a human vaccine.

Significance of the Indigenous H5N1 Vaccine

  • Disease Prevention: India has witnessed over 500 bird flu outbreaks since 2006, including around 10 lakh chicken deaths in 2006, 9 lakh in 2021 and 2 lakh in 2026.
  • Farmers’ Protection: Its affordable price of ₹1–2 per dose will make vaccination accessible to small poultry farmers and help protect their livelihoods.
  • Economic Security: Reduces poultry mortality and financial losses caused by bird flu outbreaks, strengthening the rural economy.
  • Food Security: Helps maintain poultry production and ensures the availability of poultry products.
  • Scientific Self-Reliance: Demonstrates India’s indigenous research capabilities and reduces dependence on imported animal vaccines.
  • Research Infrastructure: The proposed ₹300-crore animal disease research laboratory in Bhopal will strengthen research, disease surveillance and preparedness against emerging animal diseases.

About the Influenza A Virus

  • Influenza A is a type of influenza virus that infects humans and various animal species, including birds and mammals.
  • It is responsible for seasonal influenza outbreaks and occasional pandemics.
  • It is classified into subtypes based on two surface proteins: Haemagglutinin (H) and Neuraminidase (N).
  • Examples include H1N1, H3N2 and H5N1.

About the Subtype H5N1 (A/H5N1)

  • H5N1 is a subtype of the Influenza A virus that causes Avian Influenza, commonly known as bird flu.
  • First Identification: Identified in farmed geese in southern China in 1996.
  • Transmission: Spreads through infected birds’ saliva, mucus and faeces. It can also spread to mammals through exposure to infected animals or contaminated environments.
  • Human Infection: Rarely infects humans, mainly through close contact with infected birds or animals. Sustained human-to-human transmission has not been reported.
  • Symptoms in Birds: Respiratory distress, swollen head, watery eyes, reduced egg production and sudden death.
  • Symptoms in Humans: Fever, cough, diarrhoea and respiratory illness. Severe cases may cause pneumonia and death.
  • Classification: Avian influenza is classified as Low Pathogenic Avian Influenza (LPAI) or Highly Pathogenic Avian Influenza (HPAI), based on its pathogenicity in domestic chickens.

Government Initiatives for Animal Disease Control

  • National Animal Disease Control Programme (NADCP): Launched to control Foot and Mouth Disease and Brucellosis through vaccination.
  • FMD Vaccination: 147.16 crore free vaccine doses have been administered under the programme.
  • Lumpi-ProVacInd: Indigenous vaccine developed by scientists at Hisar and Izatnagar to combat Lumpy Skin Disease.
  • ICAR-NIHSAD: Developed indigenous vaccines for Gumboro disease, Brucella abortus S-19 Delta, Classical Swine Fever and African Swine Fever.
Shares: